Ventas

Current directors and officers who also hold a role at another S&P 500 company.

• Walter C. RakowichHST · DirectorIRM · Director
• Debra A. CafaroPNC · Director
• Matthew J. LustigBXP · Director
• Maurice S. SmithHAL · Director
• Sumit RoyO · CEO

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Sep 15, 2026

   On September 10, 2026, Ventas, Inc. (the “Company”) approved the appointment of Laurida Sayed as its Senior Vice President, Chief Accounting Officer and Controller of the Company, effective on or around October 5, 2026 (the “Effective Date”). As of the Effective Date, Robert F. Probst, the Company’s Executive Vice President and Chief Financial Officer, will no longer perform the responsibilities of Chief Accounting Officer on an interim basis. Mr. Probst will remain the Company’s Chief Financial Officer. Ms. Sayed, age 44, has served as the Chief Accounting Officer of Cushman & Wakefield Ltd. since May 2024. Prior to her appointment as Chief Accounting Officer, Ms. Sayed served as Senior Vice President, Global Corporate Controller of Cushman & Wakefield Ltd.

   Read the 8-K filing
2. Jun 15, 2026

   On June 15, 2026, Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary of Ventas, Inc. (“Ventas” or the “Company”) notified Ventas of her intention to resign from the Company effective June 26, 2026 (the “Effective Date”). Ms. Roberts intends to join Blackstone, Inc. as Senior Managing Director and General Counsel - Real Estate. She will remain in her role through the Effective Date. The Company and the Board of Directors of the Company thank Ms. Roberts for her outstanding contributions during her tenure at Ventas.

   Read the 8-K filing
3. May 15, 2026

   On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc. (the “Separation Agreement”), pursuant to which Mr. Bulgarelli will receive a payment equal to the prorated portion of his bonus under the Company’s annual incentive plan for 2026 based on target performance through the effective date of his retirement (the “Prorated 2026 Bonus”). The Prorated 2026 Bonus is in consideration for, and contingent upon, among other things, Mr. Bulgarelli’s agreement to a standard release of claims and continued compliance with his restrictive covenants.

   Read the 8-K filing
4. Feb 20, 2026

   On February 16, 2026, Gregory R. Liebbe, Senior Vice President, Chief Accounting Officer and Controller informed Ventas, Inc. (the “Company”) that he is resigning to pursue other opportunities. Mr. Liebbe’s last day of employment with the Company will be February 27, 2026. Mr. Liebbe’s decision to resign is not the result of any disagreement with the Company, including with respect to any matter relating to the Company’s accounting practices or financial reporting. Robert. F. Probst, Executive Vice President and Chief Financial Officer of the Company commented, “We are grateful for Greg’s many contributions to Ventas over the last 20 years, including the last 10 years as our Chief Accounting Officer. We wish him well in his future endeavors.” Concurrent with Mr. Liebbe’s departure, Mr.

   Read the 8-K filing
5. Nov 17, 2025

   On November 17, 2025, Ventas, Inc. (the “Company”) announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”). Mr. Bulgarelli will remain in his role through the Effective Date. Mr. Bulgarelli’s advance notice of his retirement allows lead time for the Company to conduct a comprehensive search for his replacement and for Mr. Bulgarelli to assist with the orderly transition of duties to his successor. A copy of the press release announcing Mr. Bulgarelli’s retirement is attached as Exhibit 99.1 and incorporated herein by reference.

   Read the 8-K filing
6. Mar 4, 2024

   On March 4, 2024, James D. (“Denny”) Shelton advised the Board of Directors (the “Board”) of Ventas, Inc. (we,” “us,” “our,” “Company” and other similar terms) that he will not stand for re-election as a director of the Company at the 2024 annual meeting of stockholders (the “2024 Annual Meeting”). Mr. Shelton currently serves as the Company’s Lead Independent Director and is a member of the Compensation Committee and the Nominating, Governance and Corporate Responsibility Committee of the Board. Mr. Shelton’s decision to pursue retirement follows 16 years of service on the Board and various Board committees and is not the result of any disagreement with the Company on any matter related to the Company’s operations, policies, or practices.  The Board and the Company are grateful for Mr. Shelton’s service and wish him well following his retirement from the Board.

   Read the 8-K filing
7. Mar 4, 2024

   The information set forth in Item 1.01 is incorporated herein by reference. On March 4, 2024, Theodore R. Bigman and Joe V. Rodriguez, Jr. were appointed to the Board effective immediately. The Board has affirmatively determined that each of Mr. Bigman and Mr. Rodriguez is “independent” under the rules of the New York Stock Exchange and the rules and regulations of the U.S. Securities Exchange Act of 1934, as amended. Mr. Bigman has been appointed to the Investment Committee of the Board effective immediately and Mr. Rodriguez has been appointed to the Nominating, Governance and Corporate Responsibility Committee of the Board effective immediately. Neither Mr. Bigman nor Mr. Rodriguez are a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Bigman and Mr.

   Read the 8-K filing
8. Jan 25, 2023

   Ventas, Inc. ( “we,” “us,” “our,” the “Company” and other similar terms ) has announced that J. Justin Hutchens, current Executive Vice President, Senior Housing, has been appointed to the additional role of Chief Investment Officer, effective as of January 23, 2023. In his expanded role, Mr. Hutchens will be responsible for the Company’s capital allocation strategy and execution across the enterprise, in addition to his current responsibility for the Company’s Senior Housing portfolio. John D. Cobb stepped down as Executive Vice President and Chief Investment Officer, also effective as of January 23, 2023. In order to assist with the transition, Mr. Cobb will continue to be employed by the Company in an advisory role through February 15, 2023. In connection with Mr. Cobb’s separation from employment, the Company and Mr.

   Read the 8-K filing
9. Sep 12, 2022

   On September 12, 2022, Sumit Roy, President & Chief Executive Officer at Realty Income Corporation, was appointed as an independent director to the Board of Directors (the “Board”) of Ventas, Inc. (“we,” “us,” “our,” “Company” and other similar terms) effective October 1, 2022. Mr. Roy is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Roy and any other persons pursuant to which he was selected as a director. Mr. Roy will serve on the Investment Committee of the Board. Mr. Roy will participate in the compensation arrangements for non-employee directors, including receiving an initial award of shares of restricted stock upon appointment, as described in the Company’s 2022 proxy statement filed with the U.S. Securities and Exchange Commission on March 29, 2022.

   Read the 8-K filing
10. Mar 7, 2022

    On March 7, 2022, Jay M. Gellert, a director of Ventas, Inc. (the “Company”), advised the Company’s Board of Directors (the “Board”) that he will not stand for re-election as a director of the Company at the 2022 annual meeting of stockholders (the “2022 Annual Meeting”). Mr. Gellert currently serves as a member of the Nominating and Corporate Governance, Investment and Executive Committees of the Board. Mr. Gellert’s decision not to stand for re-election did not involve any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Also on March 7, 2022, Michael J. Embler, Former Chief Investment Officer of Franklin Mutual Advisors, LLC, was appointed as an independent director to the Board effective immediately. Mr.

    Read the 8-K filing
11. Feb 2, 2021

    Effective February 1, 2021, Maurice Smith, President and Chief Executive Officer of Health Care Service Corporation, was appointed as an independent director to the Board of Directors of the Company. Mr. Smith is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Smith and any other persons pursuant to which he was selected as a director. As of the time of the filing of this Current Report on Form 8-K, the Board of Directors has not determined the committees, if any, to which Mr. Smith may be appointed. Mr.

    Read the 8-K filing
12. Jul 7, 2020

    Effective July 6, 2020, Marguerite M. Nader, President and Chief Executive Officer of Equity LifeStyle Properties, Inc., was appointed to the Board of Directors of Ventas, Inc. (the “Company”). On her appointment to the Board, Ms. Nader received a grant of 4,169 shares of restricted stock issued under the Company’s 2012 Incentive Plan, which shares vest one-half on the first anniversary of the date of grant and one-half on the second anniversary of the date of grant. A copy of the press release issued by the Company on July 6, 2020, announcing the appointment of Ms. Nader to the Board, is filed herewith as Exhibit 99.1 and incorporated in this

    Read the 8-K filing
13. Oct 21, 2019

    On October 15, 2019 (the “Effective Date”), in connection with Ventas, Inc.’s (the “Company”) May 28, 2019 announcement of his intention to retire from the Company, T. Richard Riney, the Company’s Executive Vice President, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer, retired from the Company. He also agreed to become a full-time consultant to the Company as a Senior Advisor. In connection therewith, the Company and Mr. Riney entered into a Consulting Agreement dated as of the Effective Date (the “Agreement”). The Agreement went into effect immediately upon execution and supersedes Mr. Riney’s employment agreement dated as of July 31, 1998, as amended and his Amended and Restated Change-in-Control Severance Agreement dated March 22, 2011 (the “Prior Employment Arrangements”).

    Read the 8-K filing
14. Jul 26, 2019

    Effective July 26, 2019, Sean P. Nolan, former Chief Executive Officer of AveXis, Inc., was appointed to the Board of Directors (the “Board”) of the Company. The Board also appointed Mr. Nolan to the Company’s Audit and Compliance Committee. A copy of the press release issued by the Company on July 26, 2019 announcing the appointment of Mr. Nolan to the Board is filed herewith as Exhibit 99.2 and incorporated in this

    Read the 8-K filing
15. May 29, 2019

    On May 28, 2019, T. Richard Riney, Ventas, Inc.’s (the “Company”) Executive Vice President, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer, announced his intention to retire from the Company. In order to facilitate a smooth transition of his duties and responsibilities, Mr. Riney anticipates providing continued service to the Company through the appointment and onboarding of his successor, expected by the first quarter of 2020. The Company has engaged an executive search firm and has initiated the process for securing a new General Counsel for the Company.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2021 · 2020

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.